Psychedelic Business Spotlight – June 17
This week in psychedelic business news: ARK Invest advances deep dive into psychedelic stocks; Cybin moves closer to clinical trials, and more!
psychedelics
The Four Psychedelics ETFs Capturing Investor Attention
Despite an overarching shared thesis, the four psychedelics ETFs differ in philosophy, strategy, execution, and size. This leads them to having different sized stakes companies, and their long-term success will vary.
Examining Ketamine Therapy with Myriam Barthes, Journey Clinical
In today’s episode, Myriam describes the impact of ketamine on the mind and the body, and specifically how ketamine therapy compares to other psychedelic-assisted therapies.
Encountering DMT Entities: Are they Real?
DMT is a powerful hallucinogen famous for producing experiences of encounters with entities, but how many people actually see them?
Sol Psychedelphia – A Psychedelics Community Education Event
“This event wisely explores and intentionally focuses on living better through evidence-based science and the potential that plant and entheogenic substances have for transformative healthcare”, Mia Lowry, Director of Outreach.
Psychedelic Business Spotlight – June 10
This week in psychedelic business news: Cybin acquires a Phase 1 DMT trial from Entheon; Numinus completed the acquisition of Novamind, MindMed’s stock is removed from an index; and more!
Can Psychedelics Improve Scientific Creativity?
Scientific discovery comes from creative insights, and a recently published review details how psychedelics can play a major role in scientific creativity.
The History of LSD: A Story of Self-Experimentation
Despite the LSD experience lasting only two hours, Hofmann was amazed at the power of his creation. And like any good scientist, he knew exactly what he had to do: self-experiment.
British Columbia to Decriminalize Possession of Most Drugs
Those caught with under 2.5 grams of illicit drugs, including heroin and fentanyl, will not face jail time when the regulations go into effect.
Senator’s Wife Secretly Gave Him Psilocybin to Alleviate Depression
Senator Larry Campbell, who struggles with depression, PTSD, and “getting old,” reveals that psilocybin microdoses helped improve his mood.
End of content
End of content